In contrast, decreased expression of Ten-2 was significantly associated with shortened overall survival in patients with any malignant ovarian tumor (Fig 5A), (P = .025), and highly significantly in the subgroup with serous carcinomas (Fig 5B), (P = .005). This evidence concerns the gene TENM2 and ovarian cancer.